Nova In Silico

📍 Lyon, France🗓 Founded 2010👥 58 employees💰 Last funded Feb 2020
Software Development🌐 novainsilico.ai
Website LinkedIn
Nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations. Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drugs regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials. Predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed with Jinkō®.
3
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Switzerland
1
Finland
1
France
1
Investor activity2017–2020 · investors recorded per year
2017120202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Nova In Silico?
Nova In Silico has 3 investors on record on gritt.io and 1 late-stage investors.
When did Nova In Silico last raise funding?
The most recent investment in Nova In Silico recorded on gritt.io was in February 2020.
When was Nova In Silico founded?
Nova In Silico was founded in 2010.
What industry is Nova In Silico in?
Nova In Silico operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Nova In Silico based?
Nova In Silico is headquartered in Lyon, France.